About: Nexsen Limited operates as a nanobiotechnology company that develops proprietary biosensing platforms for rapid, high-precision point-of-care (POC) medical diagnostics and point-of-use sensing for veterinary, agricultural, and biosecurity applications. The company offers Group B Streptococcus (GBS) rapid sensor, a diagnostic for the detection of human GBS in expectant mothers; kidney diseases, a POC tests for the screening, detection, and ongoing monitoring of various subsets of acute kidney injury and chronic kidney disease; bovine mastitis, a farm diagnostic to detect mastitis early which helps farmers; biosecurity pathogen tests, a portable sensor for frontline detection of invasive pests and pathogens -built for customs officers, farmers, and quarantine zones. The company was incorporated in 2021 and is based in Sydney, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.18 (-2.70%)
NXNASXNexsen Limited
Nexsen Limited share price
NXN price activity
Último preço
$ 0,180
Variação (24h)
-0,01 AUD (-2,70%)
Volume
156.29K
Volume (média 4 sem.)
-
Abertura
$ 0,19
Variação do dia
$ 0,18 - $ 0,19
Fechamento anterior
$ 0,19
Último negócio
10 Sep, 5:48 am GMT+0
Atrasado
10 Sep, 5:48 am GMT+0
NXN price performance
Atrasado
10 Sep, 5:48 am GMT+0
quote.marketSignals